Embattled TAVR Device Myval Meets Expectations in Trial, but Trouble Still Ahead

(MedPage Today) -- For a balloon-expandable transcatheter aortic valve replacement (TAVR or TAVI) platform, the much-litigated Myval performed well enough in the COMPARE-TAVI 1 randomized trial, but its rates of pacemakers and paravalvular leaks...